Author | Sandy Srinivas, MD

Articles

High-Dose Chemotherapy in Poor-Risk Germ-Cell Tumors

October 01, 2000

Testicular cancer is a highly curable cancer. However, 30% of patients are refractory to standard therapy and will need additional therapy. This article focuses on the use of high-dose chemotherapy in germ-cell tumors.